Preview
Creation Date
2020
Description
Slide 5-14: Resistance to B16 melanoma, following injection of CD1d-B16/GalCer i.v., requires CD4+ and CD8+ cells
Keywords
B16 melanoma, CD1d, CD4+ cells, α-Galactosyl ceramide, dendritic cells
2020
Slide 5-14: Resistance to B16 melanoma, following injection of CD1d-B16/GalCer i.v., requires CD4+ and CD8+ cells
B16 melanoma, CD1d, CD4+ cells, α-Galactosyl ceramide, dendritic cells